Core Laboratories (CLB) Current Leases (2022 - 2026)

Core Laboratories has reported Current Leases for 5 years, with the latest figure at $12.1 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases rose 3.8% year-over-year to $12.1 million; the trailing twelve-month figure through Mar 2026 stood at $12.1 million (up 3.8% YoY), and the FY2025 full-year result was $11.5 million, up 7.17% from the prior year.
• Current Leases for Q1 2026 stood at $12.1 million, up from $11.5 million in the prior quarter.
• The five-year high for Current Leases was $12.1 million in Q1 2026, with the low at $9.8 million in Q3 2023.
• Historically, Current Leases has averaged $11.1 million across 5 years, with a median of $11.4 million in 2024.
• Annual changes were most pronounced in 2023 — Current Leases declined 13.03% — and 2024, when it increased 16.76%.
• Core Laboratories' Current Leases stood at $11.7 million in 2022, then dropped by 13.03% to $10.2 million in 2023, then advanced by 5.06% to $10.7 million in 2024, then grew by 7.17% to $11.5 million in 2025, then grew by 5.6% to $12.1 million in 2026.
• The last three Current Leases figures came in at $12.1 million (Q1 2026), $11.5 million (Q4 2025), and $11.5 million (Q3 2025), per Business Quant data.